Pui Ying Chan

4PUBLICATIONS

28CO-AUTHORS

Molecular targetsGene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 20, 2026

Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan-Induced DNA Double-Strand Breaks in Uveal Melanoma.

|Apr 25, 2022

A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.

Pui Ying Chan, Melissa M Phillips, Stephen Ellis

|Jun 20, 2020

ctDNA monitoring using patient-specific sequencing and integration of variant reads.

Jonathan C M Wan, Katrin Heider, Davina Gale

|Jun 23, 2017

A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.

Pui Ying Chan, Peter Hall, Gordon Hay

Pageof 1

Frequent Collaborators

Jonathan C M Wan

Katrin Heider

Davina Gale

Eyal Fisher

Florent Mouliere

Angela Santonja

Dineika Chandrananda

Andrea Marshall

Andrew B Gill

Emily Barker

Frequent Collaborators

Jonathan C M Wan

Katrin Heider

Davina Gale

Eyal Fisher